Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Genitourinary 1

Conditions

Prostatic Neoplasms 11 Breast Neoplasms 3 Osteoporosis 2 Melanoma 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Kidney Neoplasms 1 Hepatoblastoma 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Anosmia 1

Interventions

pembrolizumab 28 Docetaxel 21 Gemcitabine 19 Nivolumab 15 Paclitaxel 13 Prednisone 12 Leuprolide 11 pazopanib 10 Radiotherapy 10 Cisplatin 10 Sunitinib 9 Sorafenib 9 Ipilimumab 8 Blood Specimen Collection 8 Bevacizumab 8 avelumab 7 atezolizumab 7 Therapeutics 7 Thalidomide 7 Cyclophosphamide 7 Carboplatin 7 Standard of Care 6 Radiation 6 Mitomycin 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 padeliporfin 5 enzalutamide 5 cemiplimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Absorptiometry, Photon × Genitourinary × Clear all

NCT01641172 2024-04-19

TASTY

University Medical Center Groningen

Phase 4 Completed

Anosmia, Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡